• Bloomberg


Shionogi & Co., the maker of the Crestor anticholesterol pill, has agreed to buy Sciele Pharma Inc. of the U.S. for $1.4 billion, adding research, development and sales staff.

Shareholders of Atlanta-based Sciele Pharma will receive $31 a share, Osaka-based Shionogi said Monday. The company will also pay $325 million related to a convertible bond.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.